期刊文献+

耐多药肺结核患者呼吸道感染的病原菌分布及耐药性分析 被引量:12

Distribution and drug resistance of pathogens causing respiratory tract infections in patients with multidrug-resistant tuberculosis
原文传递
导出
摘要 目的分析耐多药肺结核并发呼吸道感染患者的病原菌分布和耐药性,为临床合理用药提供参考依据。方法选取2011年8月-2012年10月住院的134例耐多药肺结核并发呼吸道感染患者为研究对象,采取患者呼吸道分泌物进行病原菌培养及分离,分析病原菌的分布特点,对主要病原菌行药敏试验,分析耐药性。结果共分离病原菌172株,排名前3位病原菌依次为肺炎克雷伯菌、白色假丝酵母菌、大肠埃希菌,分别占28.5%、19.7%、12.8%;肺炎克雷伯菌和大肠埃希菌均对亚胺培南敏感,敏感率分别为100.0%和95.5%,对头孢匹美、头孢他啶较敏感,敏感率>54.0%。结论耐多药肺结核并发呼吸道感染患者呼吸道深部痰培养出的病原菌以革兰阴性菌为主,主要革兰阴性杆菌对亚胺培南及三代以上头孢菌素类抗菌药物具有很高的敏感性。 OBJECTIVE To analyze the distribution and drug resistance of pathogens causing respiratory tract infections in patients with multidrug-resistant tuberculosis so as to guide the reasonable clinical use of antibiotics. METHODS Totally 134 multidrug-resistant pulmonary tuberculosis patients with respiratory tract infections, who were hospitalized from Aug 2011 to Oct 2012, were enrolled in the study, then the respiratory tract secretions were collected for culture of pathogens, the isolated pathogens were identified, the drug susceptibility testing for the main species of pathogens was performed, and the drug resistance was analyzed. RESULTS A total of 172 strains of pathogens were isolated, among which the glebsiella pneumoniae, Candida albicans, and Escherichia coli ranked the top three species, accounting for 28. 5%, 19. 7%, and 12. 8%, respectively. The drug susceptibility rates of the If,. pneurnoniae and E. coli to imipenem were 100.0% and 95.5%, respectively, and the drug susceptibility rates to cefpiramide and ceftazidime were more than 54.0 %. CONCLUSION The gram-negative bacilli cultured from the respiratory deep sputum obtained from the multidrug-resistant tuberculosis patients with respiratory tract infections are the predominant pathogens; the main gram-negative bacilli are highly susceptible to imipenem and more than three generation cephalosporins.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第22期5575-5576,5579,共3页 Chinese Journal of Nosocomiology
基金 重庆市万州区科学技术委员会基金项目(万州科成字2012TY015)
关键词 耐多药肺结核 呼吸道感染 病原菌 分布 耐药性 Multidrug-resistant pulmonary tuberculosis Respiratory tract infection Pathogen Distribution Drug resistance
  • 相关文献

参考文献4

二级参考文献10

共引文献21

同被引文献90

  • 1赵延玲.左氧氟沙星联合抗结核药物治疗耐多药肺结核的临床分析[J].临床研究,2014,22(5):66-66. 被引量:1
  • 2宋晓东,朱红,黄晓磊,顾晓峰,张璐.96例耐多药肺结核合并下呼吸道感染患者的菌种分布及耐药性分析[J].结核病与肺部健康杂志,2014,3(3):181-182. 被引量:3
  • 3谭守勇,黎燕琼.氟喹诺酮类药物在耐多药结核病治疗中的应用[J].中国防痨杂志,2005,27(4):267-270. 被引量:30
  • 4张贺秋,赵雁林.现代结核病诊断技术[M].北京:人民卫生出版社,2013: 50-56.
  • 5Tsivkovskii R, Sabet M, Tarazi Z, et al. Levotloxacin reduces inflam- matory cytokine levels in human bronchial epithelia cells: implications for aerosol MP - 376 ( levofloxacin solution for inhalation) treatment of chronic pulmonary infections [ J ]. FEMS Immunology Medical Mi- crobioloaw. 2011. 61(2)_. 141-146.
  • 6Phillips M,Basa-Dalay V,Blais J,et al.Point-of-care breath test for biomarkers of active pulmonary tuberculosis[J].Tuberculosis,2012,92(4):314-320.
  • 7Frahm M,Goswami N D,Owzar K,et al.Discriminating between latent and active tuberculosis with multiple biomarker responses[J].Tuberculosis,2011,91(3):250-256.
  • 8Koul A,Arnoult E,Lounis N,et al.The challenge of new drug discovery for tuberculosis[J].Nature,2011,469(7331):483-490.
  • 9Wikman-Jorgensen P, Llenas-Garcia J, Hobbins M, et al. Micro- scopic observation drug susceptibility assay for the diagnosis of TB and MDR-TB in HIV-infected patients: a systematic review and meta - analysis [ J ]. Eur Respir J, 2014, 44 (4) : 973 - 984.
  • 10Hoa NB, Khanh PH, Chinh NV, et al. Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospi- tal, Viet Nam [J]. Trup Med Int Health, 2014, 19(9) : 1076 - 1081.

引证文献12

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部